MCM
INSM icon

Manchester Capital Management’s Insmed INSM Stock Holding History

Manchester Capital Management’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$166K Sell
1,017
-3
-0.3% -$461 0.02% 293
2025
Q4 		$178K Hold
1,020
– – 0.02% 286
2025
Q3 		$147K Buy
1,020
+16
+2% +$1.96K 0.02% 360
2025
Q2 		$101K Buy
+1,004
New +$76.8K 0.01% 446
2021
Q3 		– Sell
-29
Closed -$1K – 1083
2021
Q2 		$1K Buy
+29
New +$861 ﹤0.01% 754

Other funds holding INSM

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Manchester Capital Management's INSM Position: Q1 2026 in Review

Manchester Capital Management reduced its Insmed (INSM) stake by 0.29% in Q1 2026, selling an estimated $461 and leaving 1,017 shares worth $166K. The position accounts for 0.02% of the portfolio, ranked #293.

Manchester Capital Management first reported a position in INSM in Q2 2021 and has held it in 5 quarters since. The position peaked at $178K in Q4 2025. 670 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Manchester Capital Management held 1,017 shares of Insmed worth $166K as of Q1 2026.
  • Manchester Capital Management sold 3 Insmed shares in Q1 2026, an estimated $461.
  • Insmed made up 0.02% of Manchester Capital Management's portfolio in Q1 2026, its #293 holding.
  • Manchester Capital Management first reported a position in Insmed in Q2 2021 and has held it in 5 quarters since.
  • Manchester Capital Management's Insmed position peaked at $178K in Q4 2025.
  • 670 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Manchester Capital Management's 13F filing for Q1 2026, filed 11 May 2026.